FDA Adverse Event Injury Summary report: N

STARCLOSE SE VASCULAR CLOSURE SYSTEM

MDR report key: 1842352 · Received September 18, 2010

Report

Report Number
2953144-2010-01964
Event Type
Injury
Date Received
September 18, 2010
Date of Event
April 29, 2009
Report Date
April 30, 2009
Manufacturer
ABBOTT VASCULAR - VASCULAR SOLUTIONS
Product Code
MGB
PMA / PMN Number
P050007
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL SUMMARY: THE CUSTOMER REPORTED THE DEVICE WAS DISCARDED. THE LOT NUMBER WAS NOT IDENTIFIED; THEREFORE, A DEVICE HISTORY RECORD REVIEW COULD NOT BE PERFORMED. TWENTY THREE UNUSED REP SAMPLES WITH THE SAME PART NUMBER AS THE COMPLAINT DEVICE AND THREE SEPARATE LOT NUMBERS (73043-6H, 73007-6H, 73053-6H) WERE RETURNED FOR EVAL. FUNCTIONAL TESTING WAS PERFORMED ON ALL OF THE RETURNED DEVICES AND THE DEVICES PASSED FUNCTIONAL TESTING WITHIN PRODUCT SPECS. NO MFG OR ABNORMAL OBSERVATIONS WERE DETECTED. A ROOT CAUSE FOR THE REPORTED EXPERIENCE COULD NOT BE DETERMINED BASED ON THE INVESTIGATION FINDINGS FROM THE TESTED SAMPLES. REVIEW OF THE DEVICE HISTORY RECORD FOR THIS LOT DID NOT PRODUCE ANY FINDINGS RELEVANT TO THIS REPORT.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PHYSICIAN TRAINED IN THE USE OF THE STARCLOSE SE DEVICE ACHIEVED ARTERIOTOMY CLOSURE OF THE COMMON FEMORAL ARTERY AFTER A DIAGNOSTIC PROCEDURE. REPORTEDLY, AFTER UNEVENTFUL ARTERIOTOMY CLOSURE, TISSUE TRACT BLEEDING OCCURRED UP TO FOUR DAYS AFTER THE PROCEDURE WITH SIX PATIENTS. THE BLEEDING OCCURRED BEFORE AND AFTER THE PATIENTS WERE DISCHARGED. BLEEDING WAS STOPPED WITH A SYVEK TOPICAL PAD AND MANUAL COMPRESSION. THERE WAS REPORTEDLY NO ADVERSE PT SEQUELA. NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 STARCLOSE SE VASCULAR CLOSURE SYSTEM MGB ABBOTT VASCULAR - VASCULAR SOLUTIONS NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention